Not only is it a formidable task to observe events in a contracting cell without damaging that cell, but also there is a considerable difference in species reaction to depolarizing and non-depolarizing agents which makes extrapolation of results of animal experiments to the clinical situation in man very difficult ( Figure 1 ). Comprehensive papers on the nature of neuromuscular block have been presented recently by Waud (1968) and Cookson and Paton (1969) , and the following is a very brief summary of their reviews. The endplate region of the neuromuscular junction is muscle membrane specialized for the reception of the transmitter substance acet\'lchcline and is not sensitive to electrical stimulation, I t is surrounded bv normal muscle membrane which is electrically excitable. The passage of an impulse dmvn a motor nerve releases acetylcholine, which reaches the receptors, depolarizes the endplate, and renders it highly permeable to sodium and potassium. There is a sudden change in the transmembrane potential at the endplate which results in" local action currents" which stimulate the adjacent electrically excitable membrane. V/hen the intracellular potential rises from -90 m V to -70 m V threshold is reached and there is a sudden change in the permeability of the muscle membrane which greatly increases the conductance of sodium. The sudden influx of sodium ions renders the inside of the cell positive (approximateh' +40 mY), producing a self-propagating action potential. This increased sodium conductance is extremely transient and it is followed by an increased potassium conductance which returns the transmembrane potential to resting -Approximate values of transmembrane potential in skeletal muscle at rest, during an action potential and following depolarization with suxamethonium. EKA is the value which would be assumed if the muscle membrane was completely permeable to sodium but completely impermeable to potassium ions and EK would be the value in the reverse situation. The values are taken mamly from \Vaud (1!Hi8) and Gisscn and ~astuk (1970) . levels, thus repularizing the cell. Figure ~ indicates the measured transmembrane potentials during these events.
In order to explain the mode of action of the depolarizing relaxants, it is first necessary to understand the phenomenon of "accommodation" described by Hill in 1936 . If the transmembrane potential is raised rapidly from -90 to -70 m V an action potential followed by a muscle cOlltraction will occur. If this potential is slowl v raised to -70 m V it will be found that the th;eshold has risen out of reach of the excitatory process and no action potential is produced (Figure 3) . Similarly, if the muscle membrane is held in a partially depolarized condition the threshold will remain high and the cell will enter a refractory state. THE DEPOLARIZING OR PHASE I BLOCK When suxamethonium is administered, it acts initially like acetylcholine and produces a depolarization. This is followed by a rapid rise in membrane potential to the threshold and an action potential is produced. However, suxamethonium, unlike acetylcholine, is only slowh' destroyed and consequently there is a persistence of partial depolarizatIon. under these circumstances the membrane potential assumes a value between -30 and -57 m V (Figure 2 ) (Gissen and Nastuk 1970) , the threshold rises and the post-junctional membrane becomes electrically inexcitable.
Although " local action currents", which originate from the action of acetylcholine on the endplates, may persist, the increase in membrane potential so produced is insufficient to reach threshold ( Figure 4 ). THE DESENSITIZING, PHASE II Or{ DeAL BLOCK l"nder certain circumstances the nature of the neuromuscular block produced by suxamethonium alters so that it superficially resembles a "competitive" block of the type seen with d-tubocurarine. This biphasic action of depolarizing agents was described by a number of workers (Zaimis 1952, Kamigo and Taylor J 954) . Churchill-Davidson (1955) suggested that both types of block might be present at the same time and such " dual blocks" occurring in man were described. These were characterized by prolongation of suxamethonium action, a " non-depolarizing" muscle twitch response and reversibility with neostigmine (Grant 1952 ; Brennan 1956 '; Paton J9.5ti; Foldes 1957; Churchill-Davidson, Christie and Wise 1960; Katz, Wolf and Papper 1963) .
-A diagrammatic representation of the phenomenon of accommodation. (A) A rapidly rising local action potential easily reaches threshold (U) and initiates an action potential. (B) When the membrane potential (V) is raised slowly by artificial (electrical) means the threshold rises out of reach and there is no excitation produced. (C) Suxamethonium produces a rapid rise with excitation initially, followed by a subsequent artificially raised transmembrane potential which leads to accommodation and muscle paralysis.
The mechanism of production of " dual block" is not understood. It has been postulated that it is due to a temporary loss of integrity of the endplate membrane which results in a passive 4.-A diagrammatic interpretation of the primary mode of action of suxamethonium. Administration initially produces an action potential which is followed by a phase of persistent depolarization resulting in a raised threshold. During this phase (A) nervous stimulation will not produce local action potentials of sufficient magnitude to reach threshold. As the depolarization wanes (H), threshold falls and strong nervous stimulation at this stage can initiate an action potential (taken from 'Vaud (1968)). distribution of ions inside and outside the membrane. This leads to a loss of the chemical response of the neuromuscular junction, which is then said to be " desensitized". This type of block appears to be fundamentally different from the" competitive" block of d-tubocurarine (Table 1 ) and a number of authors would prefer to use the term " desensitization block" rather than "phase II" or "dual block" to make this point (Gissen, Katz, Karis and Papper 1966) . A great deal of confusion has arisen in regard to the "depolarizing" and "desensitizing" nature of suxamethonium action. This has been mainly due to poor understanding of the mode of onset, dose-relationship and reversibility of the "desensitizing" block. The simple peripheral nerve stimulator has been of major assistance in the investigation of these problems (Christie and Churchill-Davidson 1958 , Cohen 1963 , Churchill-Davidson 1965 , Ross 1970a . The use of such stimulators, often with a device to display the electromyogram or quantitatively to measure muscle contraction (e.g. a force transducer), has been described by many workers (Churchill-Davidson and Christie 1959 ; Churchill-Davidson, Christie and Wise 1960; de Jong and Freund the entrance of the drug into the' interior of the muscle fibre (Churchill-Davidson and Katz 1966) . A number of authors believe that both blocks are present from the outset but that the depolarizing one is rapid in onset but short in duration, while the desensitizing one is slow in onset and of slightly longer duration. Katz and Ryan (1969) found that a single intravenous dose of 5 mgjkg of suxamethonium produced a depolarizing block while 10 doses of 0·5 mgjkg produced a longer, desensitizing block. Similarly intramuscular injections readily give rise to desensitization (Walts and Dillon 1967) . Continuous infusions produce a similar effect, but larger doses are required than with intermittent injections (Crul et al. 1966) .
NERVE STIMULATION PATTERN
with the drug (Churchill-Davidson and Katz 1966; Katz and Ryan 1969) . Even allowing for variations in serum cholinesterase and tachyphylaxis in different individuals, there is a very wide range of responses to suzamethonium. Administration of the "standard dose" to a susceptible individual may therefore result in considerable overdosage. The main precaution that can be taken to prevent prolonged apnoea is the constant monitoring of the degree of neuromuscular block by means of the nerve stimulator. If the twitch height is kept depressed to 10 per cent of the normal value there will be adequate relaxation during the administration with a rapid return of muscle power when the drug is discontinued. 
DESENSITIZATION BLOCK AND PROLONGED APNOEA
The administration of suxamethonium, by infusion or intermittent injection, to normal individuals, has frequently led to prolonged apnoea. White (1963) concluded that the drug was unsuitable for use in operations which last more than 20 minutes because of this risk. Although it has been widely reported that the apnoea was due to the development of "dual block" there is now good evidence that the complication was due mainly to overdosage Another cause of prolonged apnoea in patients who receive suxamethonium is the ill-advised use of anticholinesterases in an attempt to reverse desensitization block (Vickers 1963 . Although it is true that neostigmine will antagonize a pure desensitizing block, objection to its use is made on the following grounds. First, it is believed by some that the desensitization block lasts only slightly longer than the depolarization block, and so, per se, does not cause prolonged apnoea. Second, it is impossible to determine Anaesthesia and Intensive C£re, Vol. I, No. 3, February, 1973 the ratio of depolarizing to desensitizing block in a given situation. If, for instance, 70 per cent of the neuromuscular junctions were completely depolarized and 30 per cent were partially desensitized, the nerve stimulator would indicate a desensitization block (since the completely paralysed fibres would not contract). Under these circumstances the administration of neostigmine would potentiate rather than antagonize the block (Gissen, Katz, Karis and Papper 1966; Churchill-Davidson and Katz 1966) .
Certain conclusions can be made on the role of the peripheral nerve stimulator in interpretation of the suxamethonium block. First, as an indicator of the predominant type of block present it has not lived up to expectations. It is, however, an invaluable tool in the differentiation of central from peripheral" apnoea", in the assessment of the degree of neuromu,;cular block present and in the monitoring of drug response.
COMPARISOK OF SUXAMETHONIUM .\};D DECAMETHONIUM
\Vith an in-vitro frog nerve-muscle preparation Gissen and Nastuk (1970) were able to demonstrate distinct differences between the modes of action of equipotent doses of suxamethonium and decamethonium. They examined the rate of onset of action, the electrical changes in the post-junctional membrane and the predominant nature of the block produced (Table 2) . Despite approximately equal rates of access of the drugs to the receptor sites, the onset of decamethonium action was much slower. It is generally accepted that depolarization block requires a post-junctional membrane potential of between -30 and -57 mV. This was seen with suxamethonium but, surprisingly, with decamethonium muscle fibres had a mean membrane potential of -61 m V. Large endplate potentials could be generated on nerve stimulation in the decamethonium-blocked preparation but, contrary to expectation, these were unable to initiate propagated action potentials. Suxamethonium produced a block which was predominantly of a depolarizing type, while the decamethonium block was more desensitizing in nature. Finally, by washing the muscle preparation the action of suxamethonium could be more readily terminated than the action of decamethoniuri'-!.
The authors concluded that suxamethonium was a better depolarizing drug than decamethonium and that, since desensitizing block was poorly understood and unpredictable, suxamethonium was a safer drug in the clinical situation. This interpretation of the results of the experiments was greatly criticized by Galindo (] 971), who felt there was no justification for the extrapolation from amphibian muscle in the laboratory to man in the operating theatre. SC:X;"l\IETHo),"rC:l1 ;"),"1) l\luscLE OXYGE),"
CO};SL\IPTION \Yhen suxamethoniulll is infused intravenousl\' there is an increase in oxygen consumptioi1 by the skeletal muscles (l\luldoon and Theye 1969; Theye ]970). \Yith total paralysis there is an initial rise in oxygen uptake to a maximum of 60 per cent above the resting level within l;"J minutes of the start of administration. This increase corresponds to the period of muscle fascicnlation seen with suxamethonium. If the paralysing infusion is continued, the oxygen consumption falls within half an hour to a new level approximately 20 per cent above the resting value. This level of uptake persists until the infusion is stopped. The initial peak is not seen if the paralysis is only partial and it may be abolished bv pre-treatment with paralysing doses of a non-depolarizing agent. In both these situations, however, the secondary sustained increase in oxygen uptake persists ( Figure 6 ). The reason for this persistent elevation is unknown but it has been suggested that this is due either to the increased energy requirements of the muscle cell in the face of sustained membrane depolarization or to cholineinduced sarcomeric oscillations. The latter are brief asynchronous, small-amplitude contractions of sarcomeres which eventually produce peristalsis-like movements.
The importance of these observations and their application to clinical anaesthesia is not clear. However, it has been shown that three minutes of preoxygenation prior to thiopentone-suxamethonium induction produces adequate Pa0 2 levels for at least four minutes (Nolan 1967). Thus it might be concluded that the increased muscle oxygen consumption produced by suxamethonium administration is not of great clinical significance.
HOURS 10 FIGURE 6.~The two stages of increased muscle oxygen consumption which occur in suxamethonium induced neuromuscular block. This response is modified when subparalysing doses of the drug are used or when pretreatment with non-depolarizing agents is employed.
FACTORS AFFECTING THE NEUROMUSCULAR BLOCKING ACTION OF SUXAMETHONIUM
(1) Temperature The effect of cooling on the action of suxamethonium has been studied in isolated rat diaphragm (Bigland et al. 1958 , Freeman 1968 ), in cats and dogs (Bigland et al. 1958 ) and in human subjects (Zaimis, Cannard and Price 1958; Cannard and Zaimis 1959) . In all cases the magnitude and duration of action were increased by cooling, the nature of the block was unchanged and the effects were reversed by re-warming. In cats the block increased fourfold when the temperature was lowered from 36 0 C to 31 0 C.
Decamethonium was potentiated to a similar degree, which indicates that the increased activity of suxamethonium was not due simply to cholinesterase inhibition. Cooling, on the other hand, antagonized the action of d-tubocurarine. Despite these experimental findings potentiation of suxamethonium has not always been observed in patients subjected to induced hypothermia (Bookallil 1972) .
(
2) Acid-Base State
In 1958 Payne demonstrated that, in the cat, inhalation of carbon dioxide increased the action of d-tubocurarine but opposed the actions of suxamethonium, decamethonium, gallamine and dimethyl-d-tubocurarine. Sodium carbonateinduced alkalosis also potentiates suxamethonium in the cat (Katz, Ngai and Papper 1963) . These effects appear to follow alteration of the plasma pH, with subsequent modification of neuromuscular transmission, plasma binding of relaxants and ionization of the relaxant molecules, which has been described previously (Kalow 1954) .
Suxamethonium antagonism in acidaemia has not been demonstrated in man, in fact a mild potentiation has been recorded (Table 3) . Baraka (1967) felt that these conflicting results could be explained on the basis of species difference. Potentiation of depolarizing agents and inhibition of nondepolarizers in acidaemia in man can be partially explained by depression of cholinesterase and acetylcholinesterase activity (optimum action at ])H 8 '5).
3) Fluid and Electrolyte State
The effect of fluid depletion on suxamethonium action is very complex. There is some increase in relaxant concentration, but there is also greater enzymatic hydrolysis and protein binding due to the increase in plasma protein concentration, Reduced blood flow causes abnormal distribution and decreased excretion, and allows increased hydrolysis of the drug to occur before it reaches the neuromuscular junction. Cellular dehvdration in itself decreases muscular excitability, Finally, dehydration is often associated with electrolyte and ;'cid-base imbalance. Since numerous factors are involved, the effect of dehydration on suxamethonium action is not predictable (Foldes 1959, Feldman HH(3) .
Hyponatraemia occurring clinically or produced experimentally by substitution of sucrose or lithium for sodium, appears to have little effect on the action of suxamethonium (Foldes 19H9, Freeman 19(8) .
The effect of potassium on the activity of muscle relaxants is largely dependent on the ratio of the intracellular and extracellular concentrations of the ion which determines the state of polarization of the cell membrane (Table cl) . In the commonest form of potassium imbalance there is loss from both compartments without significant change in the transmembrane potential or the action of muscle relaxants. \Vhere there is predominanth' a low extracellular potassium suxamethonium is antagonized, and when a higll extracellular potassium predominates suxamethonium is IJotentiated (Fcldman 1963, Freeman 19(8) .
Calcium is intimatel\' concerned in neuromuscular transmission, promoting the release of acetdcllOline, raising the threshold of excitatioll (post-junctional " membrane stabilizing" action) and facilitating excitatiollcontraction coupling (Foldes 19iJ9, Freeman 19t18, Radola et al. H17I) . It also has an activating effect on serum cholinesterase (van de l\Ieer 1 !l53) , Manhofer reported a case of prolonged apnoea following suxamethonium administration in a In'pocalcaemic patient in 19;'):2 and was first to suggest the clinical importance of calcium in depolarizing blocks. Irwin, Wells and Whitehead (19il6), working with dogs and rats, and Freeman (J !HiS) , using rat diaphragm, examined this problem and concluded that a high calcium level antagonized, and a low calcium level potentiated, suxamethonium block. Freeman maintained that the pre-synaptic membrane was an important site of suxamethonium action and that at tl1e nerve endings the drug competed with calcium ions, leading to a reduction of acetylcholine release. Other workers (Badola et al. 1971) , however, were unable to demonstrClte any such antagonism between calcium and suxamethonium, although they noted that once desensitization block was established the paralysis was increased b.v the administration of calcium ions. I t is well known that magnesium IOns can produce neuromuscular blockade. Thev mav also potentiate the action of muscle relaxants and several authors have warned of the danger of using these agents in patients on magnesium therapy (Giesecke et al. ] 968, Ghoneim and Long 1970, Aviet and Crawford 1971) . Using rat diaphragm preparations and non-paralysing concentrations of magnesium ions, considerable potentiation of d-tubocurarine and decamethonium, and moderate potentiation of suxamethonium, has been demonstrated (Figure 7) .
The action of magnesium is antagonistic to that of calcium, inhibiting the release of acetvlcholine. It also reduces the effect of acetylcholine at the motor endplate and desensitizes the post-synaptic membrane.
(J) Immaturity
Several authors have reported that premature and newborn infants appear resistant to the action of depolarizing relaxants (Stead 1955 , Telford and Keats 1957 , Bush 1963 , Churchill-Davidson and Wise 1963 , 1964 , and that sensitivity to these agents increases with age ( Table 5 ). The types of reactions seen in the neonate, especially in the first two weeks of life, are distinctlv different from those seen in the adult. The "electromyographic response to twitch may be normal, but tetanus is poorly sustained. W'ith suxamethonium there are no fasciculations and the block tends to be of a desensitizing type.
Fade may occur with repeated single twitches and is marked on tetanic stimulation. A short period of posttetanic facilitation is followed by a prolonged exhaustion phase ( Figure 5 ). There is sensitivity to non-depolarizing agents and the similarity hetw'~en the immature neuromuscular junction and that seen in myasthenia gravis has been frequently remarked upon. It takes three to six months for the infant to develop neuromuscular transmission of the adult type. A further point of interest is that the cholinesterase level in the newhorn is often as low as 10 per cent of the normal. While there is little doubt that the mechanism of action of suxamethonium is different in neonates and adults, there is considerable doubt about the so-called" resistance" of the neon ate to the drug. Crawford, Terry and J{ourke (1950) correlated drug dosage and blood levels attained in children and submitted that drugs should be administered on a surface area rather than a weight criterion. On this basis Walts and Dillon (1969a) found there was little difference between neonatal and adult requirements and that the recommended dose based on surface area was approxil1latcl~' twice that based on the patient's weight ( Table 6) . A pharmacokinetic study of the patients of \Valts and Dillon indicated that the quantitative responses of neonates were essE'ntially similar to those of adults (Levy 1970) . (9) and the Americans were found, in fact, to have a considerably longer re coven' time than the English. Levy (1 !l70) demonstrated that this was not duE' to a lower minimulll effective dose or different dose-response curve slope in the Americans, but was entirE'lv due to slow elimination of the drug.
(6) Other Factors
Mam· other factors such as cholinesterase level, °drug interaction and disease processes mav affect the action of suxamethoniul1l. These will be dealt with in some detail at a later stage. DOSE AXI) AU}IIXrSTlV,:rrox Dose response curves for suxamethonium have been plotted for both man and experimental animals. Degree of respiraton' depression, duration of apnoea, and in-vivo and in-vitro muscle twitch responses have been used as indices in these studies (Thesleff HJ52, Espinosa and Artusio 19G-!, Kalow and Cunn 1957, Salgado 1963 , Freeman HW1-I, Katz and Rvan 19@, Choneim and Long HJ70). Kalow and Gunn administered anaesthesia to patients undergoing repeated electroconvuisi\'e therapy and hy giving a different dose of suxamethoniul11
OIl each occasioIl were able to construct doseresponse curves for each individual (Figure 8) . \Yhile there was a wide variation in response, there was a linear relationship between "log dose" and "log duration of apnoea". The slope of this line was the same in all patients. I t would also appear that the slopes of such curves are species-dependent (man 0·6:)7, cat o ·-!Hi). The most important factor in determining the response of a normal individual is his serum cholinestE'rase le\'el. This effect is predominant and tends to obscure lesser correlations with hodyweight and age.
Further evidence of wide individual variation was presented b:v' Katz and Ryan (1969) . The\' studied the effect of suxamethonium, in single dose or continuous infusion, on the stimulated muscle -twitch in anaesthetized patients. Following a single dose of O·f) mg/kg of the drug, the time taken to regain 90 per cent of the original twitch height was between -!·2 and 16 minutes (fourfold variation). The rate of infusion required to maintain 90 per cent depression of the twitch height was 1·7-1!")·:! mg/kg/hr (ninefold variation). Even allowing for differences in cholinesterase level, age and other factors there is a large unexplained individual variation in the response to suxa-methoniuI1l.
Therefore the importance of monitoring the degree of neuromuscular block with a nerve stil11ulator during continuous infusion should be stressed, as this should (From Kalow and (; unn (1ll57}.) prevent the development of prolonged apnoea as a result of drug overdosage.
Tachyphylaxis with suxamethonium has been demonstrated in experimental and clinical studies. Working with isolated rat diaphragm, Freeman (1968) showed that several factors were involved (Table 7) . The only clinical circumstance where tachyphylaxis IS of practical importance occurs when suxamethonium is injected repeatedly over a short period of time. In this situation a tachyphylaxis of 30-70 per cent has been demonstrated (Katz and Ryan 1969) . Some authors (Payne and Holmdahl 1959, Poulsen and Hougs ]958) have recorded tachyphylaxis with continuous infusion, but this was not confirmed by others. 
ROUTE OF ADMINISTRATION
Suxamethonium is usually given as a single intravenous injection but it may also be given by intermittent intravenous injection, continuous intravenous infusion, or bv the intramuscular, intralingual and intra-arterial routes. Appropriate dose ranges are indicated in Table 8 . It is generally recommended that intravenous administration should be preceded by atropine in children (to prevent vagal arrhythmias) and by a non-depolarizer in adults (to prevent muscle pain and other side-effects).
Intramuscular injection of the drug into the deltoid, quadriceps femoris or pectoralis major is useful in infants and children (Bush 1963) .
In combination with hyaluronidase it has also been used in adults (Cooke et al. 1963) . Muscle fasciculations are not seen when the drug is given intramuscularly (Foldes 1959) .
Prolongation of action in infants due to poor muscle blood flow and hypothermia has been recorded with this mode of administration. The use of intralingual suxamethonium is not recommended as it may cause arrhythmias, and haematoma or haemorrhage in the mouth. Using doses of 1 mg/kg, Mazze and Dunbar (1968) showed that, although the onset and duration of neuromuscular block produced by intralingual injection were intermediate between those of intravenous and intramuscular administration, the incidence of ventricular arrhvthmias was very high. These arrhythmias' were not abolished by pre-treatment with atropine and the mechanism of their production was not elucidated. Intra-arterial infusion of suxamethonium is occasionally used in experimental procedures (Roberts and Little 1961, Gissen et al. 1966) . Its advantages are firstly that hydrolysis of the drug is minimized, allowing a more accurate assessment of its concentration at the neuromuscular junction, secondly that only small doses are required as dilution is minimal, and finall~' only those muscles under study are affected. (1) The Non-depolarizing Relaxants The mutually antagonistic behaviour of depolarizing and non-depolarizing agents has been demonstrated by various authors (Paton and Zaimis 1949 , Hutter and Pascoe 1951 , Brennan 1956 ). The addition of a depolarizing agent to a system in which a non-depolarizer is acting raises the resting potential of the muscle membrane and allows otherwise ineffective local action currents to reach threshold (Waud 1968) . Similarly, the addition of a non-depolarizer to a system blocked by a depolarizing agent tends to lessen the block by favouring repolarization. The interaction of drugs such as suxamethonium and d-tubocurarine is further complicated by the development of desensitization and some authors have advised against the use of such combinations (Hamer, Hodges and Foldes 1956) .
In anaesthetic practice there are three common situations in which one type of relaxant is administered while the other type is still acting: (a) d-Tubocurarine may be given before the action of an intubating dose of suxamethonium has worn off. This decreases the maximum intensity of the non-depolarizing block. (b) Suxamethonium may be administered at the end of the operation to assist closure of the A lIaestlzesia and Intensive Care, Vol. J, No . .), Februllr\', 1.'173 19-! abdomen. This produces partial reversed of the d-tubocurarine block and reduced intensity and duration of suxamethonium action. (cl Pretreatment with sub-paralvsing doses of a nOI1depolarizer has been used to prevent adverse side-effects of suxamethonium such as fasciculations, post-operative muscle pains, myoglobinuria, hyperkalaemia and raised intragastric and intra-ocular pressures (\\'alts and Dillon 1969b) . Cullen (1 H71) noted that if gallamine 10-20 mg was given three minutes prior to the injection of suxamethonium the dose of the latter required to produce adequate intubating circumstances the action of cl-tubocurarine and pancuronium may he potentiated (Katz et aL. 19G9, Katz 1 D71) . When pancuronium is injected 20 minutes after suxamethoniuI1l, its intensit\· and duration of action are hoth increased b\' more than 50 per cent.
Interactions between muscle relaxants art' Yen' complicated.
They may antagonize, potentiate, or have no apparent effect on each other. Factors which are important in determining the outcome of an interaction are the sequences of administration, doses us('d and nll'thocb used to assess tlll' dfects. conditions was 1"') mg/kg as compared with 1 mg/kg in patients who were not pre-treated. Similar findings were reported by' Freucd and Rubin (1972) . :VIiller ar,d Way (1971) examined this same problem using a muscle twitch depression method but were unable t() demonstrate anv inhibition of suxamethonium bv gallamine -pre-treatment. Commenting on these apparently contradictory findings, \\'ollman (1971) stated that there often was difficulty interpreting and correlating clinical and experimental data of this type. A further unusual interaction of muscle relaxants may occur when a non-depolarizing agent is given after the effect of an initial d()~e of suxamethonium has worn off. l :nder these (2) The VoLatile A llaesthetic .1gcnts
Dieth\"l ether anaesthesia produces Illuscle rclaxati()1l in ib own right, mainly hy' a central action but also by a weak neuromuscular blocking action (K'atz 1966).
It markedl\" increases the effect of d-tubocurarine and in a bout half the population slightl\· potentiates the action of suxamethonium. Cyclopropane antagonizes the depolarization block of suxamethonium hut has no effect on its desensitizing block. Since cyclopropane potentiates the action :)f d-tubocurarine this is clear evidence of the different natures of competitive and desensitizing blocks (Sabawala and Dillon 19!il Currie, 1953 Leatherdale et al. , 1959 Newnam and Loudon, 1966 Commoner in females Cooke et al. , 1963 Borchert, 1968 Hegarty, 1956 No l{eference to muscle pain following suxamethoniulll administration was made b\' HoufIle, Collier and Somers (HH52) and Currll' (IH:J:~). Churchill-Davidson (IHiJ4) was the first to investigate fulh' the incidence and s('\·(Tit\· of such pains.
Various workers rqlorted a high incidence of muscle pain in am hulant patients following the use of suxamethonium. The incidence and se\'crit\' was much less in silllilar patients who were confined to bed (Table 1I ). The pclin generalk appearcd on the first post-operatin' day', hut it ma\' initiall\' occur on the third or sullsequent cia':'s (Burifes and Tl1n~tall Hltil). It most frequcnth' affects the neck, shoulder,;, pectoral and upper abdol1linal region:; and has been likened to mu:;cle stiffness which f()II()\\'~ violent ph\'~ical exercise in the unfit imli\'idual (Churchill-Da\'idson 1 H:JI; Hurtles and Tunstall IHfil). It has also heen descrihed as similar to pleuris\' ancl the neck stiffness which occurs in polionwelitis or meningitis (Prince Hi!)!). The pain is reliewd h\' rcst and exacerbated h\' muscular activii\'. It i~ generall\' accepted that the incidence of tIll' pain is maximum in middle life and rare at extremes of age. Fem,des are affected much more than males (Tahle H). The pain frequenth' lasts two to three da,'s, but up to six da\'s has heen recorded.
Yarious factor~ haH' becn implicated in the etiolog\' of " scoline pains" such as mechanical injur\' due to fascicuiations, release of lactic acid, ]l\'poxia, the presence of breakdown products of suxametllOniul1l and potassium release frol1l the muscle fibres (Dottori, Liif and Y gge I !Wfi, Gupte and Savant 1H71).
Several authors ha\'l~ shO\\'n that the scverit\, of the pains is not dirccth' related to the violenc'e of fasciculation (Table 10 ) and in fact Waters and :'Iapleson (IBIl) have proposed an inverse relationship. Thev postulated that muscle fibres arc connected to one another bv a pain-sensiti\'e fascia. \Vhcn a synchronous contraction occurs this fascia is undamaged, but where there is an as\'nchronous contraction fascial damage is produced and pain follo,,"s ( Figure H) . Coarse h\'itching is regarded as a manifestation of a relativel\' s\'nchronous contraction and is in fact generalh· followed h\' a low incidence of pain. This also accords with the observation that the maximum pain-producing damage (" noxious activity") occurs when doses of ~uxall1ethoniulll in the medium range are administered. Small doses (e.g. continuous infusion) should affect few fibres and produce little damage. Large doses (e.g. a single injection for intubation) produce relatively s\'nchronous fasciculations with minimal fascial ciamage. Intermediate doses (e.g. intermittent injection) result in full contractions of some fibres with little affect on others, thus exhihiting IllaxilllUIIl noxIOus acti\'itv" intermittent injections are therefore lll()n~ likely to produce post-operative muscle pain than single intravenous injections, intramuscular injection or continuous infusion.
Because the stiffness following suxamethoniurn administration had been descrihed as similar to that which followed unaccustomed exercise, K ewnam and Loudon ( 19(6) investigated muscular fitness as a possible aetiological factor. They found a positive correlation, postoperative pains being seven times as COllllllon in the unfit when compared with fit individuals. They also proposed that the low incidence of pain in children was due to their innate activity and fitness.
. The t~'pe of operative procedure performed has considerable bearing on tile incidence of suxamethonium pains. Foster (1960) showed that pains were very COlllmon after radiological procedures (aortogram, air encephalogram) hut rare after upper ahdominal or thoracic surger~·. Pollard (H)72) also pointed out that the pains are rare with use for electroconvulsive therap\·. Patients undergoing a course of such therap\' rarely complain of "scoline pains" except on the first occasion, when the\' are usually mM. "
Effcctiw' reduction of the incidence of muscle pain and stiffness has been produced hy pretreatment with gallamine :20 mg or d-tubocurarine 8 -;') rng given two to three minutes before the injection of suxamethoniulll (Table  10) .
:-.J 0 protection is afforded if the nOlldepolarizing agents are given with or after the suxamethoniulll. PancuroniuIll is said to be less effective than gallamine or d-tubocurarine. Pre-treatment reduces or abolishes subsequent muscle fasciculation and increases the dose of suxamethonium required for intubation or continued paralY,;is (Cullen 1 \)71; Dottori, Uif and Y\ye H)fi;')). Some protection is also offered by the intravenous induction agents (Burtles and Tunstall 1 m)1; Clarke, Dundee and Da w HW-t; Craig l!HjJ; Ross 1 !l70/;). The eugenol derivatives (propanidicl and G.:2!L,)03) and methohexitone are lllore effective than thiopentone and thialharhitone.
The greatest protection is afforded when tile interval between intravenous induction and suxamethonium administration is small. Recentl\', Cupte and Savant (1971) showed that pretreatment with large doses of vitamin C considerabh' reduced the incidence and severitv of " scoline' pains". The\' had been influencecl b~' reports that vitamin C alle\'iated the muscle pain which followed strenuous exerci:-;e.
Other drugs \\'hich slightly reduce the incidence of pain ;lrc procallle (:\lorris ,wd Dunn 1 \l:,)7) , decamethonium (Hegarh lH;')ti, Prince-\\'hite 1937), tacrine (Barrm\' and Smethurst 1 !W:3) and " BerizYl1l ", an aneurin di:-;ulphide/cocarboxylase combination (Dotturi, Liif and Ygge 1!Hl3). Foster (\9tiO) reported that neostigmine was ineffecti\'e, but Borchert (\ (HiH) demonstrated appreciable protection. It is conceivable that anticholinesterases act 1)\' increasing the "effecti \'e dose" of suxamethonium reaching the lllot(1r enciplates, tlms keeping it well above the level of maximal "noxious activity". Chlorpromazine (:\Iorris and Dunn \ H37) and " (~cnnanin ", an inhibitor of succinyl!nonocholine (Dottori, Liif and Y ggc 1 !Hi3; ~ ewnam and Loudon 19ti6) ha\'e 1)('cn shown to afford no protection at all.
Finally, the substitution of sllxetllOniulll for sllxamet-hon ium (Parbrook and Pierce ] 960, Burtlcs 1 \It) \) or the use of suxamethoniulll bromide instead of the chloride (Lcatherdale et al. 1 ()3!J, Foster \ \l(0) has not lead to am' reduction in the incidence of " sCCJline pains'" IllagllL'siul11 h~yels an(l 111agnesiul11 irisilicate therapy in lahour ". Hr it . ./ . . 111I/csth., 43, IS:). IladoIa, 1<. I'., Chatterji, S., I'and('y, K., and i(umar, S. 
